Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al.

Research output: Contribution to journalLetterOther

Original languageEnglish
Pages (from-to)363 - 364
Number of pages2
JournalCardiovascular Drugs and Therapy
Issue number5
Publication statusPublished - 2013

Cite this